Detalhe da pesquisa
1.
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
J Natl Compr Canc Netw
; 17(4): 302-310, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959462
2.
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
J Natl Compr Canc Netw
; 15(5): 563-573, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476736
3.
Hepatobiliary cancers, version 2.2014.
J Natl Compr Canc Netw
; 12(8): 1152-82, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25099447
4.
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events.
Clin Lung Cancer
; 23(8): 686-693, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050243
5.
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study.
J Clin Oncol
; 35(2): 157-165, 2017 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27870574